Pharmacological modulation of Hh impacts the major critical features of cancer cells: the proliferation, the migration, and the crosstalk with components of proximal stroma, supporting the use of SMO inhibitors such as sonidegib and vismodegib for melanoma therapy. The gene discussed is SMO; the disease is melanoma.